Issue Date: January 10, 2011
Amyris Signs Deal For Squalane Production
Renewable chemicals firm Amyris has signed agreements with two partners to convert bioderived farnesene into finished specialty chemicals. The first product will be squalane, a triterpene primarily used in cosmetics. Glycotech will provide the chemical processing at a facility in Leland, N.C., owned by Salisbury Partners. The plant can also provide finishing services for lubricants, polymers, and fuels that Amyris plans to make. The firm previously reported that its farnesene will be manufactured by Biomin in Brazil and Tate & Lyle in Illinois.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society